Advanced search
Publication Cover
Ophthalmic Genetics Volume 39, 2018 - Issue 6
Submit an article Journal homepage
269
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

A novel missense mutation in BEST1 associated with an autosomal-dominant vitreoretinochoroidopathy (ADVIRC) phenotype

Fukutaro ManoDepartments of Ophthalmology, Mayo Clinic, Rochester, MN, USAView further author information
,
Stephen A. LoBueDepartments of Ophthalmology, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0003-2899-7730View further author information
ORCID Icon,
Timothy W. OlsenOphthalmology Research, Mayo Clinic, Rochester, MN, USAView further author information
,
Alan D. MarmorsteinOphthalmology Research, Mayo Clinic, Rochester, MN, USAView further author information
&
Jose S. PulidoDepartments of Ophthalmology, Mayo Clinic, Rochester, MN, USA;Ocular Oncology, Mayo Clinic, Rochester, MN, USA;Vitreoretinal Diseases, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
View further author information
Pages 749-753 | Received 30 Apr 2018, Accepted 03 Sep 2018, Published online: 17 Sep 2018

References

  • Kaufman SJ, Goldberg MF, Orth DH, Fishman GA, Tessler H, Mizuno K. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1982;100(2):272–78.
  • Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, Perveen R, Reddy MA, Bhattacharya SS, Traboulsi E, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45(10):3683–89. doi:10.1167/iovs.04-0550.
  • Blair NP, Goldberg MF, Fishman GA, Salzano T. Autosomal dominant vitreoretinochoroidopathy (ADVIRC). Br J Ophthalmol. 1984;68(1):2–9.
  • Vincent A, McAlister C, Vandenhoven C, Heon E. BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies. Eye (Lond). 2011;25(1):113–18. doi:10.1038/eye.2010.165.
  • Chen CJ, Kaufman S, Packo K, Stohr H, Weber BH, Goldberg MF. Long-term macular changes in the first proband of autosomal dominant vitreoretinochoroidopathy (ADVIRC) due to a newly identified mutation in BEST1. Ophthalmic Genet. 2016;37(1):102–08. doi:10.3109/13816810.2015.1039893.
  • Boulanger-Scemama E, Sahel JA, Mohand-Said S, Antonio A, Condroyer C, Zeitz C, Audo I. Autosomal dominant vitreoretinochoroidopathy: when molecular genetic testing helps clinical diagnosis. Retina. 2018. doi:10.1097/IAE.0000000000002041.
  • Traboulsi EI, Payne JW. Autosomal dominant vitreoretinochoroidopathy. Report of the third family. Arch Ophthalmol. 1993;111(2):194–96.
  • Chen CJ, Goldberg MF. Progressive cone dysfunction and geographic atrophy of the macula in late stage autosomal dominant vitreoretinochoroidopathy (ADVIRC). Ophthalmic Genet. 2016;37(1):81–85. doi:10.3109/13816810.2014.889171.
  • Oh KT, Vallar C. Central cone dysfunction in autosomal dominant vitreoretino choroidopathy (ADVIRC). Am J Ophthalmol. 2006;141(5):940–43. doi:10.1016/j.ajo.2005.11.041.
  • Boon CJ, Klevering BJ, Leroy BP, Hoyng CB, Keunen JE, Den Hollander AI. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res. 2009;28(3):187–205. doi:10.1016/j.preteyeres.2009.04.002.
  • Kellner S, Stohr H, Fiebig B, Weinitz S, Farmand G, Kellner U, Weber BH. Fundus autofluorescence and SD-OCT document rapid progression in autosomal dominant vitreoretinochoroidopathy (ADVIRC) associated with a c.256G > A mutation in BEST1. Ophthalmic Genet. 2016;37(2):201–08. doi:10.3109/13816810.2015.1033556.
  • Carter DA, Smart MJ, Letton WV, Ramsden CM, Nommiste B, Chen LL, Fynes K, Muthiah MN, Goh P, Lane A, et al. Mislocalisation of BEST1 in iPSC-derived retinal pigment epithelial cells from a family with autosomal dominant vitreoretinochoroidopathy (ADVIRC). Sci Rep. 2016;6:33792. doi:10.1038/srep33792.
  • Johnson AA, Guziewicz KE, Lee CJ, Kalathur RC, Pulido JS, Marmorstein LY, Marmorstein AD. Bestrophin 1 and retinal disease. Prog Retin Eye Res. 2017;58:45–69. doi:10.1016/j.preteyeres.2017.01.006.
  • Burgess R, MacLaren RE, Davidson AE, Urquhart JE, Holder GE, Robson AG, Moore AT, Keefe RO, Black GC, Manson FD. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet. 2009;46(9):620–25. doi:10.1136/jmg.2008.059881.
  • Goldberg MF, McLeod S, Tso M, Packo K, Edwards M, Bhutto IA, Baldeosingh R, Eberhart C, Weber BHF, Lutty GA. Ocular histopathology and immunohistochemical analysis in the oldest known individual with autosomal dominant vitreoretinochoroidopathy. Ophthalmol Retina. 2018;2(4):360–78. doi:10.1016/j.oret.2017.08.001.
  • Lafaut BA, Loeys B, Leroy BP, Spileers W, De Laey JJ, Kestelyn P. Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol. 2001;239(8):575–82.
  • Han DP, Lewandowski MF. Electro-oculography in autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1992;110(11):1563–67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.